Sustainability + Impact
For more than a decade, Sofinnova Partners has been investing in companies that apply biotechnology to develop sustainable solutions in agriculture, food, chemicals and materials.
We're an environmental impact strategy, with a focus on early-stage investments, helping entrepreneurs build teams and knowledge networks. We find the right financial and industrial partners so that companies we invest in have multiple options.
Close | Fund | AMT |
---|---|---|
2012 | Sofinnova Green Seed Fund | €22.5 million |
2017 | Sofinnova IB I | €125 million |
2021 | Sofinnova IB II | €175 million |
Close: 2012
Fund: Sofinnova Green Seed Fund
AMT: €22.5 million
Close: 2017
Fund: Sofinnova IB I
AMT: €125 million
Close: 2021
Fund: Sofinnova IB II
AMT: €175 million
- FeatureSofinnova Industrial Biotech2023 Impact Report: A hands-on investment strategy driving positive change for the planet
Read all about how the entrepreneurs we support are working to make industry and agriculture more sustainable
"We could easily live without an Uber. It's not going to change our lives if we just have to flag a taxi. But tomorrow if we run out of food, that's a big problem. If we destroy the environment, that's a big problem."
“Founders need to have grit, to be able to move mountains and stay resilient when things are not easy. Creativity and charisma are important, of course, but resilience is a very key feature.”
"If you want to find a deeptech investor, able to make a strong impact and help you make progress in industrial biotech — Sofinnova is it."
"We are on a mission to find deeptech solutions with strong environmental impact that can truly change the world for the better."
The
Team
Michael Krel
Partner, Sofinnova Partners - Industrial Biotech Strategy
Joško Bobanović
Partner, Sofinnova Partners - Industrial Biotech Strategy
Mary McCarthy
Partner, Sofinnova Partners - Industrial Biotech Strategy
Guillaume Baxter
Partner, Sofinnova Partners - Industrial Biotech Strategy
Anna Belousova
Associate, Sofinnova Partners - Industrial Biotech Strategy
Mariam Cherifi
Associate, Sofinnova Partners - Industrial Biotech Strategy
Gabriela Sachet Fernandez
Analyst, Sofinnova Partners - Industrial Biotech Strategy
Companies
Industrial Biotech
Afyren
Industrial Biotech
Avantium
Industrial Biotech
Biosyntia
Industrial Biotech
Biotalys
Industrial Biotech
Bon Vivant
Industrial Biotech
CelluComp
Industrial Biotech
Comet Biorefining
Industrial Biotech
DMC Biotechnologies
Industrial Biotech
DNA Script
Industrial Biotech
Elicit Plant
Industrial Biotech
EnginZyme
Industrial Biotech
Meiogenix
Industrial Biotech
MetGen
Industrial Biotech
Micropep Technologies
Industrial Biotech
Microphyt
Industrial Biotech
Novameat
Industrial Biotech
Prometheus Materials
Industrial Biotech
Protera
Industrial Biotech
Pyrowave
Industrial Biotech
RE:CHEMISTRY by GFBio (formerly GFBiochemicals)
Crossover & Industrial Biotech
Synthace
Industrial Biotech
Werewool
0 results
Related News
Biotalys announces closing of private placement
Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signalling a key step towards commercialisation
Arzeda secures $38M in oversubscribed funding round to advance protein design commercialization efforts
Novameat raises €17.4M oversubscribed Series A round led by Sofinnova Partners and Forbion
Biotalys receives approval for large-scale demonstration trials of EVOCA in the Netherlands